A single serum glucose measurement predicts adverse outcomes across the whole range of acute coronary syndromes.
about
Hyperglycaemic index as a tool to assess glucose control: a retrospective studyThe effects of intravenous insulin infusions on early mortality for patients with acute coronary syndromes who present with hyperglycaemia: A matched propensity analysis using data from the MINAP database 2008-2012.A review of the use of insulin protocols to maintain normoglycaemia in high dependency patients.Ultra-acute increase in blood glucose during prehospital phase is associated with worse short-term and long-term survival in ST-elevation myocardial infarction.Glycemic variability and outcome in critically ill.Hyperglycaemia after Stage I palliation does not adversely affect neurodevelopmental outcome at 1 year of age in patients with single-ventricle physiology.Impact of admission serum glucose level on in-hospital outcomes following coronary artery bypass grafting surgery.Is glycaemia or insulin dose the stronger risk factor for coronary artery disease in type 1 diabetes?Effect of abnormal fasting plasma glucose level on all-cause mortality in older patients with acute myocardial infarction: results from the Beijing Elderly Acute Myocardial Infarction Study (BEAMIS)Blood glucose management in the patient undergoing cardiac surgery: A review.Impact of diabetic status on the hyperglycemia-induced adverse risk of short term outcomes in hospitalized patients with acute coronary syndromes in the Middle East: findings from the Gulf registry of Acute Coronary Events (Gulf RACE)Relationship between admitting nonfasting blood glucose and in-hospital mortality stratified by diabetes mellitus among acute coronary syndrome patients in oman.Acute Phase Hyperglycemia among Patients Hospitalized with Acute Coronary Syndrome: Prevalence and Prognostic SignificanceGlucose and collagen regulate human platelet activity through aldose reductase induction of thromboxane.Ethnicity and variation in prognosis for patients newly hospitalised for heart failure: a matched historical cohort study.Major impact of admission glycaemia on 30 day and one year mortality in non-diabetic patients admitted for myocardial infarction: results from the nationwide French USIC 2000 studyHyperglycemia in the hospital setting: the case for improved control among non-diabetics.On Arrival High Blood Glucose Level is Associated With Detrimental and Fatal Hospitalization Outcomes for Acute Coronary Syndrome.Acute insulin resistance in myocardial ischemia: causes and consequences.Hyperglycemia and outcome after myocardial infarction and cardiac surgery: so what?The prognostic significance of serum glucose levels after the onset of ventricular arrhythmia on in-hospital mortality of patients with acute coronary syndromeBlood glucose and its prognostic implications in patients hospitalised with acute myocardial infarction.The prognostic value of blood glucose level on admission in non-diabetic patients with acute myocardial infarction.An overview of glycemic control in the coronary care unit with recommendations for clinical management.Glycaemic control in acute coronary syndromes: prognostic value and therapeutic options.Hyperglycemia in acute coronary syndromes: from mechanisms to prognostic implications.Association between hyper- and hypoglycaemia and 2 year all-cause mortality risk in diabetic patients with acute coronary events.Glycemic Control during Coronary Artery Bypass Graft Surgery.Glycemic variability and mortality in critically ill patients: the impact of diabetes.Association of Hyperglycemia with In-Hospital Mortality and Morbidity in Libyan Patients with Diabetes and Acute Coronary Syndromes.The prognostic role of in-hospital peak glycemia in stemi patients with and without diabetes.Prognostic value of erythrocyte sedimentation rate in ST segment elevation myocardial infarction: interaction with hyperglycaemia.Admission glycaemia and outcome in patients with acute coronary syndrome.Admission hyperglycemia is associated with failed reperfusion following fibrinolytic therapy in patients with STEMI: results of a retrospective study.Duration of time on intensive insulin therapy predicts severe hypoglycemia in the surgically critically ill population.Admission blood glucose helps predict 1 year, but not 2 years, mortality in an unselected cohort of acute general medical admissions.Hyperglycemic events in non-intensive care unit patients receiving parenteral nutrition.[The prevalence of diabetes and stress hyperglycemia in the acute myocardial infarction patients].The association between hyperglycaemia on admission and 180-day mortality in acute myocardial infarction patients with and without diabetes.Hemoglobin A1c is a better predictor of prognosis following the non-ST elevation acute coronary syndrome than fasting and admission glucose.
P2860
Q24791110-D29736CC-7FEB-4133-9C5C-22E6A9764469Q30848885-04A18FC4-E159-4147-9F20-1DA401758F3DQ33267162-45F0A914-127F-4665-A389-BD3EFEACB1A4Q33622028-542E1488-FDE8-4189-A7BC-094A08C330BAQ33719438-8B8C4003-03E6-49A3-BFA7-DFDE98F99F54Q33734163-80B679CF-E79A-4AED-9A18-1A6E129FC3FCQ33776403-5CCB0FEC-AF47-472D-BD2F-79175DEF07ECQ33833060-C36CCD21-B115-422C-AF1F-A27D26C561BAQ34541855-D8C66E56-9B06-4834-A3F8-6668AF57427AQ34574042-FE668A4A-ADE0-4F86-82C2-06B877223189Q34723358-4E3F29BE-AF40-49C0-BE7A-3066C7214BA1Q35069085-940C277A-87E2-4327-94F0-0EDE38213992Q35324130-E2452E95-EDDF-426C-B047-7A5A38E51087Q35485016-55FEE640-3F9E-47A9-9DDB-0378AE8CA7AAQ35585101-A53793C3-82D8-4E4D-9447-5A889A0A2C98Q35771073-F42D39DB-26D1-4234-9063-96D0B9CC698DQ36035243-CF05680C-7074-4356-9BFA-1D1384E8C6E8Q36326204-C04EF15E-E8F6-4650-9DA3-3EBD6EF8401FQ36588698-1F29CC9D-0876-4C3B-9C10-286DAAEA04CDQ36588701-C46515E4-B6D1-4D62-9AF0-C964CA793E06Q36839334-42A7F9DD-AE83-43CB-987A-A824DB8DD977Q37311107-B772682C-6176-4EE4-A5B7-6D43978F0364Q37314571-6560C064-0A4E-41D0-A458-BFBBBE1B565FQ37453099-ABAACA5C-6418-480C-9154-A34CF151EBCDQ37762321-ABB8F9AF-2DCE-49DD-8A0B-7E04AD386DBBQ38551004-83669A8C-09B8-46E3-BC59-0589A6EDD6ABQ40431693-EF347522-83B6-4E1A-AC4B-A2A4C705E1C3Q41731510-973E2478-B46D-4BC1-B8FF-10A9636C39DBQ41839821-250089CB-CB3C-4D12-AE1D-75B7B6C57BB0Q41959610-03C1B10F-3AFB-4843-8E91-A143634D5877Q43736877-2B512AFF-8EEB-43AB-95B0-5CE0346A54CBQ43747202-172524D0-35A0-4329-BE63-D121EEB4CF05Q43832101-34853907-6AD7-491D-AD4F-34212B1F0331Q44649222-F1E09A53-341D-42D6-9AB9-F5ECD2495B12Q44850027-95C86B68-781E-403B-BDEF-9A3C8202474AQ44941936-9FE945BF-EB48-4E9D-8A2E-6425034A9FB4Q45947315-D2AB1570-411D-42F7-8777-EF1F2E4B07B1Q46573003-FB995FAE-87A3-4A61-96FD-9211A6A62AD2Q46714453-510C9BEC-2B48-4299-BBA5-ED3476E0B310Q51330574-48AFEB3F-9623-446E-AF5E-FB72917AB6DA
P2860
A single serum glucose measurement predicts adverse outcomes across the whole range of acute coronary syndromes.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
A single serum glucose measure ...... e of acute coronary syndromes.
@ast
A single serum glucose measure ...... e of acute coronary syndromes.
@en
type
label
A single serum glucose measure ...... e of acute coronary syndromes.
@ast
A single serum glucose measure ...... e of acute coronary syndromes.
@en
prefLabel
A single serum glucose measure ...... e of acute coronary syndromes.
@ast
A single serum glucose measure ...... e of acute coronary syndromes.
@en
P2093
P2860
P356
P1433
P1476
A single serum glucose measure ...... e of acute coronary syndromes.
@en
P2093
A D Timmis
K Ranjadayalan
P2860
P304
P356
10.1136/HEART.89.5.512
P407
P577
2003-05-01T00:00:00Z